We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.2B
AUM Growth
-$91.8M
Cap. Flow
-$238M
Cap. Flow %
-4.58%
Top 10 Hldgs %
22.29%
Holding
328
New
43
Increased
93
Reduced
100
Closed
61

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$38.2M
2
CCL icon
Carnival Corporation Ltd
CCL
+$37.7M
3
WBA
Walgreens Boots Alliance
WBA
+$35.3M
4
ICLR icon
Icon
ICLR
+$30.9M
5
CELG
Celgene Corp
CELG
+$29.8M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$63.8M
2
DHR icon
Danaher
DHR
+$50.4M
3
AZO icon
AutoZone
AZO
+$36.8M
4
AGN
Allergan plc
AGN
+$33.9M
5
BIIB icon
Biogen
BIIB
+$33.5M

Sector Composition

Rank Sector Weight
1 Technology 25.03%
2 Healthcare 24.38%
3 Financials 20.66%
4 Communication Services 10.61%
5 Consumer Discretionary 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICLR icon
51
Icon
ICLR
$12.8B
$30.8M 0.59%
+457,530
New +$30.9M
MEOH icon
52
Methanex
MEOH
$4.32B
$28.2M 0.54%
506,410
+225,452
+80% +$12.7M
BABA icon
53
Alibaba
BABA
$269B
$28.2M 0.54%
342,480
+58,404
+21% +$5.02M
HAL icon
54
Halliburton
HAL
$27.9B
$27.9M 0.54%
647,109
-159,164
-20% -$7.33M
AXE
55
DELISTED
Anixter International Inc
AXE
$27.6M 0.53%
424,234
-190,013
-31% -$13.5M
LLY icon
56
Eli Lilly
LLY
$1.07T
$27.5M 0.53%
330,000
-433,100
-57% -$33M
TRIP icon
57
TripAdvisor
TRIP
$1.59B
$27.5M 0.53%
315,677
+59,980
+23% +$4.88M
ACHC icon
58
Acadia Healthcare
ACHC
$3.17B
$27.5M 0.53%
350,500
-33,473
-9% -$2.41M
RARE icon
59
Ultragenyx Pharmaceutical
RARE
$2.65B
$26.8M 0.52%
262,061
-63,467
-19% -$4.93M
EVHC
60
DELISTED
Envision Healthcare Holdings Inc
EVHC
$26.7M 0.51%
225,951
-37,909
-14% -$4.31M
Y
61
DELISTED
Alleghany Corp
Y
$26.6M 0.51%
56,700
-1,300
-2% -$625K
ESPR
62
DELISTED
Esperion Therapeutics
ESPR
$26.4M 0.51%
323,388
-53,665
-14% -$5.25M
DVAX
63
DELISTED
Dynavax Technologies
DVAX
$26.2M 0.5%
1,119,533
-88,951
-7% -$1.94M
ENDP
64
DELISTED
Endo International plc
ENDP
$26.2M 0.5%
+328,500
New +$28.4M
TEL icon
65
TE Connectivity
TEL
$58.8B
$25.3M 0.49%
393,501
-184,053
-32% -$12.7M
JAZZ icon
66
Jazz Pharmaceuticals
JAZZ
$15.9B
$25.2M 0.48%
143,113
+1,054
+0.7% +$189K
SPLK
67
DELISTED
Splunk Inc
SPLK
$25M 0.48%
358,520
-15,288
-4% -$1.03M
BRK.B icon
68
Berkshire Hathaway Class B
BRK.B
$1.07T
$24.8M 0.48%
182,000
-18,000
-9% -$2.57M
LRCX icon
69
Lam Research
LRCX
$382B
$24.7M 0.47%
3,032,440
-296,040
-9% -$2.32M
SU icon
70
Suncor Energy
SU
$77.7B
$24.5M 0.47%
797,138
+232,846
+41% +$7.04M
UHS icon
71
Universal Health Services
UHS
$9.43B
$24.2M 0.46%
170,000
+9,945
+6% +$1.25M
FTRPR
72
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
$24M 0.46%
+241,500
New +$24.2M
PTLA
73
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$23.6M 0.45%
517,626
-50,021
-9% -$2.01M
NXPI icon
74
NXP Semiconductors
NXPI
$68B
$23.4M 0.45%
238,106
-32,291
-12% -$3.31M
IQV icon
75
IQVIA
IQV
$34.7B
$23.3M 0.45%
320,836
-9,164
-3% -$628K
1 2
3
4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Polar Capital held 328 positions worth $5.2B, down 1.7% from $5.29B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital withdrew a net $238M in Q2 2015, closing 61 positions and reducing 100 holdings. Its most notable exit was Danaher, an estimated $50.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital opened a new position in Stryker worth $38.5M.

  • Polar Capital's largest Q2 2015 buy was Stryker: 402,973 shares worth $38.5M.
  • Polar Capital added most to Celgene Corp in Q2 2015, an estimated $29.8M increase.
  • Polar Capital's biggest Q2 2015 reduction was Merck, cutting an estimated $63.8M.
  • Polar Capital fully exited Danaher in Q2 2015, selling an estimated $50.4M.
  • Polar Capital's ten largest holdings make up 22% of its $5.2B portfolio in Q2 2015.
  • Polar Capital opened 43 new positions and closed 61 in Q2 2015.
  • Polar Capital's portfolio value fell 1.7% quarter-over-quarter to $5.2B.

Based on Polar Capital's 13F filing for Q2 2015, filed 14 Aug 2015.